BioCity Biopharma - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Can SAGA Metals Corp. turn a Rio Tinto castoff into Quebec’s next titanium discovery story? (TSXV: SAGA)

What Olaplex Holdings, Inc.’s $2.06-per-share buyout by Henkel AG & Co. KGaA signals for beauty sector consolidation (NASDAQ: OLPX)

What Cadre Holdings, Inc.’s $10.3m acquisition signals about consolidation in tactical gear markets (NYSE: CDRE)

Rhinebeck Bank taps MANTL for omnichannel account opening as Alkami Technology (ALKT) accelerates post-acquisition integration

Kidney and urinary disorders Understanding major conditions, terminology, and their role in human health

Read More

6 minute read

Pharma Industry News

BioCity’s SC0062 secures second breakthrough therapy designation in China for diabetic kidney disease

BioCity Biopharma’s ETA-selective SC0062 earns second Breakthrough Therapy Designation in China for diabetic kidney disease, reinforcing its CKD potential.

byPallavi Madhiraju

June 26, 2025

web analytics